chr8-143719060-T-A
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_139021.3(MAPK15):c.485T>A(p.Leu162Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000795 in 1,589,194 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.00076 ( 0 hom., cov: 31)
Exomes 𝑓: 0.00080 ( 0 hom. )
Consequence
MAPK15
NM_139021.3 missense
NM_139021.3 missense
Scores
2
9
8
Clinical Significance
Conservation
PhyloP100: 2.92
Genes affected
MAPK15 (HGNC:24667): (mitogen-activated protein kinase 15) Enables MAP kinase activity and chromatin binding activity. Involved in several processes, including dopamine uptake; positive regulation of DNA metabolic process; and regulation of organelle organization. Located in several cellular components, including Golgi apparatus; autophagosome; and microtubule organizing center. Biomarker of breast cancer. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MAPK15 | NM_139021.3 | c.485T>A | p.Leu162Gln | missense_variant | 6/14 | ENST00000338033.9 | NP_620590.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MAPK15 | ENST00000338033.9 | c.485T>A | p.Leu162Gln | missense_variant | 6/14 | 1 | NM_139021.3 | ENSP00000337691 | P1 | |
MAPK15 | ENST00000395107.8 | c.536T>A | p.Leu179Gln | missense_variant | 6/8 | 1 | ENSP00000378539 | |||
MAPK15 | ENST00000395108.2 | c.485T>A | p.Leu162Gln | missense_variant | 6/8 | 1 | ENSP00000378540 | |||
MAPK15 | ENST00000484654.1 | n.574T>A | non_coding_transcript_exon_variant | 6/12 | 1 |
Frequencies
GnomAD3 genomes AF: 0.000756 AC: 115AN: 152140Hom.: 0 Cov.: 31
GnomAD3 genomes
AF:
AC:
115
AN:
152140
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000656 AC: 132AN: 201298Hom.: 0 AF XY: 0.000725 AC XY: 79AN XY: 109016
GnomAD3 exomes
AF:
AC:
132
AN:
201298
Hom.:
AF XY:
AC XY:
79
AN XY:
109016
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000800 AC: 1149AN: 1436936Hom.: 0 Cov.: 41 AF XY: 0.000766 AC XY: 546AN XY: 712826
GnomAD4 exome
AF:
AC:
1149
AN:
1436936
Hom.:
Cov.:
41
AF XY:
AC XY:
546
AN XY:
712826
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000755 AC: 115AN: 152258Hom.: 0 Cov.: 31 AF XY: 0.000833 AC XY: 62AN XY: 74438
GnomAD4 genome
AF:
AC:
115
AN:
152258
Hom.:
Cov.:
31
AF XY:
AC XY:
62
AN XY:
74438
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
8
ExAC
AF:
AC:
84
Asia WGS
AF:
AC:
2
AN:
3478
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 13, 2024 | The c.485T>A (p.L162Q) alteration is located in exon 6 (coding exon 6) of the MAPK15 gene. This alteration results from a T to A substitution at nucleotide position 485, causing the leucine (L) at amino acid position 162 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Uncertain
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T;.;.
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
.;D;D
M_CAP
Uncertain
D
MetaRNN
Benign
T;T;T
MetaSVM
Benign
T
MutationAssessor
Uncertain
M;.;M
MutationTaster
Benign
D;D;D
PrimateAI
Uncertain
T
PROVEAN
Pathogenic
D;D;D
REVEL
Uncertain
Sift
Uncertain
D;D;D
Sift4G
Pathogenic
D;T;D
Polyphen
D;.;.
Vest4
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
DS_AG_spliceai
Position offset: 2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at